CDX2 and malignant colon neoplasm: As miR-196b was found [7] to be directly activated by the CDX2 intestinal-specific transcription factor [11], implicated in colon cancer pathogenesis [12–14], we sought to determine whether miR-196b expression was misregulated in colorectal cancer (CRC).